Shutterstock, Gorodenkoff
The Court of Appeal in London has ruled that an investment treaty award requiring the Czech Republic to pay US$750 million to a blood plasma company must be set aside – while rejecting the state’s bid to revive a challenge to the tribunal’s jurisdiction over a co-claimant.
To read more
Subscribe to Global Arbitration Review
Register for limited access
Register for free to receive GAR’s daily briefing and access to GAR 100.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Already have access? Login below